✦ LIBER ✦

Thromboxane A2 Synthase Inhibitors Prevent Production of Infectious Hepatitis C Virus in Mice With Humanized Livers

✍ Scribed by Abe, Yuichi; Aly, Hussein Hassan; Hiraga, Nobuhiko; Imamura, Michio; Wakita, Takaji; Shimotohno, Kunitada; Chayama, Kazuaki; Hijikata, Makoto

Book ID: 120420834
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 482 KB
Volume: 145
Category: Article
ISSN: 0016-5085
DOI: 10.1053/j.gastro.2013.05.014

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

654 PRODUCTION OF INFECTIOUS HEPATITIS C

654 PRODUCTION OF INFECTIOUS HEPATITIS C VIRUS IN A PRIMARY CULTURE OF HUMAN LIVER SLICES

✍ S. Lagaye; H. Shen; J. Gaston; M. Nascimbeni; M. Triyatni; P. Bourdoncle; V. Mal 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Liberation of vasoactive substances and

Liberation of vasoactive substances and its prevention with thromboxane A2synthase inhibitor in pig liver transplantation

✍ Itsuo Yokoyama; Takaaki Kobayashi; Masataka Negita; Shuji Hayashi; Motohiko Yasu 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 540 KB

There are multiple causes of liver graft nonfunction in the early post-transplant period. Since a severe microcirculatory disturbance based on ischemia-reperfusion liver injury is considered to be the main underlying pathophysiology, it is suspected that various vasoactive substances are liberated a

Liberation of vasoactive substances and

Liberation of vasoactive substances and its prevention with thromboxane A2 synthase inhibitor in pig liver transplantation

✍ Itsuo Yokoyama; Takaaki Kobayashi; Masataka Negita; Shuji Hayashi; Motohiko Yasu 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 514 KB

HCV796: A selective nonstructural protei

HCV796: A selective nonstructural protein 5B polymerase inhibitor with potent anti-hepatitis C virus activity In Vitro, in mice with chimeric human livers, and in humans infected with hepatitis C virus

✍ Norman M. Kneteman; Anita Y. M. Howe; Tiejun Gao; Jamie Lewis; Dan Pevear; Gary 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 248 KB

## Anti -hepatitis C virus (HCV) drug development has been challenged by a lack of experience with inhibitors inclusive of in vitro, animal model, and clinical study. This manuscript outlines activity and correlation across such a spectrum of models and into clinical trials with a novel selective

Genetic variability of hepatitis C virus

Genetic variability of hepatitis C virus NS3 protein in human leukocyte antigen-A2 liver transplant recipients with recurrent hepatitis C

✍ F. Xavier López-Labrador; Marina Berenguer; Amparo Sempere; Martín Prieto; Rafae 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 200 KB 👁 1 views

The association between the severity of chronic hepatitis C and the variability of the hepatitis C virus (HCV) genome remains controversial, but to our knowledge few data are available to date regarding T-cell epitope coding regions in transplant patients. In the current study, we identified 21 huma